Siemens Healthineers’s CFO on Earnings, Guidance, Covid Tests

The transcript discusses the company's decision to raise its guidance for comparable sales, largely due to increased demand for antigen testing. It highlights strong growth in diagnostics and imaging, with a focus on recovery in the US and European markets. The conversation also touches on the company's involvement in COVID test kits and potential opportunities in emerging markets.

What percentage increase in comparable sales guidance is attributed to antigen testing?

• 10%

• 50%

• 100%

• 75%

What is the expected revenue from antigen tests according to the updated guidance?

• €300 million

• €500 million

• €750 million

• €1 billion

Which region is showing the fastest recovery in imaging demand?

• United States

• Europe

• Asia Pacific

• Middle East

Which countries are major customers for the company's COVID test kits?

• Germany, Austria, France

• United States, Canada, Mexico

• Brazil, Argentina, Chile

• China, Japan, South Korea

What recent regulatory achievement did the company receive for its COVID test kits?

• ISO certification

• WHO endorsement

• FDA approval

• CE mark for layperson testing